Zensun Sci & Tech, Ltd., a biopharmaceutical company based in Shanghai and San Diego, announced today positive results of four completed Phase 2 clinical trials including three double-blind, placebo-controlled studies conducted in China and Australia and interim results from the United States Phase 2 trial for Zensun’s innovative “first-in-class” anti-heart failure drug, Neucardin™.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61677-zensun-completes-clinical-trials-of-neucardin-treatment-of-heart-failure
When Georges Favre-Jacot started his watchmaking company in 1865, he was already convinced that emotion arises from a combination of daring and authenticity. Later, to suggest that his brand offered the ultimate in expertise and high standards, he renamed the company after the highest point in the sky: Zenith.
As an integral part of a brand’s heritage, values enable the brand to construct a “moral framework,” a guideline that underlies all of its external and internal discourse. Zenith’s values have always clearly shown through in its decisions, actions, and collections.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60648-zenith-watchmaking-daring-vistas
The most stressful week of the year is upon us; the last week of holiday shopping. As consumers across the country seek those last minute gifts, their stress levels rise. Zazen Bear, the retailer whose concept is about connection, harmony and peace, is offering consumers gifts that inspire finding those moments of peace in your day.
To celebrate this season, Zazen Bear has released a video series, titled “Zen Tree,” to showcase their jewelry collections while giving the viewer a sense of relaxation and peace. Every Holiday Season, consumers decorate trees to reflect the festive spirit; whether it is with ornaments, lights, garland, or a combination of all, each tree has its own specific design. Zazen Bear took this holiday staple, visualizing it with a peaceful and minimal aesthetic. The “Zen Tree” series celebrates the Holiday Season by presenting the Zazen Bear jewelry collections as ornaments decorating a forest of Christmas trees.
To view the multimedia release go to:
http://www.multivu.com/players/English/7656031-zazen-bear/
Millions of Americans will enjoy their Fourth of July celebrations this year while watching fireworks. Many will be at public displays in their community, while others will be using consumer fireworks in the backyard. Zambelli Fireworks is reminding Americans to focus on safety — especially at home.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/zambellifireworks/44704/
Zaha Hadid Architects and Roca are delighted to announce the opening of a brand new flagship space, the Roca London Gallery, at Imperial Wharf close to Chelsea Harbour. Zaha Hadid Architects were commissioned to create this unique concept which takes its inspiration from the power of water as a transforming element and which will bring the Roca London Gallery to life.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/roca/52146/
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
A phase 1 clinical trial of the drug crizotinib achieved remissions, with minimal side effects, for 10 of the children participating in a clinical study carried out by the multicenter Children’s Oncology Group (COG). The results were “an exciting proof-of-principle” for the targeted treatment, said the study leader, Yaël P. Mossé, M.D., a pediatric oncologist at The Children’s Hospital of Philadelphia.
“We are entering a new era of cancer therapy, in which we use knowledge of basic biology to design very specific drugs that target cancer cells with potentially less side effects on healthy tissue,” said Mossé. “In addition, as we concentrate on targets in molecular pathways, we move away from an exclusive focus on one form of cancer to customizing treatments according to biological activity. Abnormal ALK activity occurs in subtypes of neuroblastoma and subtypes of lymphoma, so identifying ALK activity in individual patients may enable us to provide the most effective care.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/50776-childrens-hospital-philadelphia-lymphoma-neuroblastoma-oncology-gene-trial
zNitro (znitro.com), a Clear Protector company, today announced it will launch its exclusive lineup of Nitro electronics accessories at the Macworld/iWorld Show 2013. zNitro will be located at Booth 809 in the Moscone Center of this gala San Francisco event scheduled for January 31- February 2, 2013.
Building on the exceptional reputation for quality established by its Clear Protector predecessor, zNitro will continue to offer outstanding value and top-of-the-line products for consumers.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59895-former-clear-protector-znitro-mobile-electronic-devices-accessories
Chocolate milk brand YUP! and digital media company Onion, Inc. are rallying teens and young adults across the nation to join the ‘Nothing Hour’ movement.
The beverage brand is shaking up the chocolate milk market by bringing an unconventional twist to a familiar category, using social marketing to appeal to young adults and teens rather than the usual mom and kid target.
To view the multimedia release go to:
http://www.multivu.com/players/English/7862951-the-onion-yup-nothing-hour/
World Water Day is March 22, and the children and youth of Children International are celebrating around the world. They know firsthand the difference clean, accessible water can make in their lives.
Some of them also know what it feels like to make clean water available to others. In 2012, the youth of Children International in Lusaka, Zambia, dedicated their Youth Empowerment Fund to extend the supply of clean, piped water to the poor community of Chibolya.
To view Multimedia News Release, go to http://www.multivu.com/mnr/57995-children-international-world-water-day
Walden University Scholars of Change focus on the future, whether they are transforming the way children learn, mentoring, or improving living conditions for others. More than 175 Walden University students and alumni submitted inspiring videos of social change in their communities for the university’s 2014 Scholars of Change video contest. These scholars–along with hundreds of their fellow video contributors–are supporting Walden’s mission by putting their knowledge to use for the greater good.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7388451-walden-university-scholars-of-change/
Children International’s 2013 Youth Report is available beginning today, International Youth Day. The report explains how Children International’s youth programs, with community centers at the core, measurably change outcomes for impoverished youth. The majority of the world’s 1.7 billion young people ages 10 to 24 live in developing countries – many in extreme poverty where they routinely confront threats to their personal safety and progress. Without positive intervention like Children International’s successful youth programs, these at-risk youth can remain trapped in an intergenerational cycle of poverty.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/57997-children-international-2013-youth-report-results-now-available
In partnership with Men’s Health Network (MHN), Prostate Health Education Network (PHEN), ZERO – the End of Prostate Cancer and Joe Torre, four-time world champion baseball Hall-of-Famer and prostate cancer survivor, Genomic Health, Inc. (Nasdaq: GHDX) today launched Your Prostate Your Decision to educate prostate cancer patients and their loved ones that every man is different and every cancer is unique, and a genomic test can clarify the aggressiveness of one’s disease prior to invasive treatment. This first-of-its-kind national effort aims to address concerning results of a large national survey that found low general awareness about prostate cancer aggressiveness and treatment options, underscoring the need for better understanding of active surveillance as a treatment plan.
“For a man with prostate cancer, a single decision can change his entire life,” said Mr. Torre, reflecting on his own experience with prostate cancer. “When I was diagnosed with prostate cancer, I faced a game-changing decision. While I chose surgery, a less aggressive approach called active surveillance might be the best choice.”
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7322251-your-prostate-your-decision-joe-torre-talks-about-prostate-cancer-genomic-testing-treatment-options-psa/
